Inventor · disambiguated record
Daisy M. Shah
Also filed as: SHAH DAISY · SHAH DAISY M · SHAH DAISY MANISH
12 granted patents·3 pending applications·31 citations·filing 2005–2019
86Inventor score
Top patents by PatentIndex Score
15 records- 0187US9855229B2Treatment of respiratory disorders using ROR-gamma inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2016·Granted Jan 2, 2018·12 cites·5 claims
- 0284US7230002B2Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereofGLENMARK PHARMACEUTICALS LTD·Filed 2005·Granted Jun 12, 2007·6 cites·29 claims
- 0384US7205323B2Dipeptidyl peptidase IV inhibitors pharmaceutical compositions containing them, and process for their preparationGLENMARK PHARMACEUTICALS SA·Filed 2005·Granted Apr 17, 2007·8 cites·51 claims
- 0477US7538128B2Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing themGLENMARK PHARMACEUTICALS SA·Filed 2007·Granted May 26, 2009·3 cites·47 claims
- 0570US7524844B2Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing themGLENMARK PHARMACEUTICALS SA·Filed 2007·Granted Apr 28, 2009·1 cites·51 claims
- 0665US9682977B2Bicyclic heteroaryl indole analogues useful as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2014·Granted Jun 20, 2017·1 cites·11 claims
- 0763US10336688B2Carbocyclic compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2018·Granted Jul 2, 2019·0 cites·10 claims
- 0862US10988467B2Compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2019·Granted Apr 27, 2021·0 cites·9 claims
- 0953US10344024B2Compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2018·Granted Jul 9, 2019·0 cites·9 claims
- 1049US9975887B2Compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2016·Granted May 22, 2018·0 cites·27 claims
- 1146US2011184027A1Tissue selective stearoyl-coa desaturase 1 inhibitors and cell based screening assay for their identificationGLENMARK PHARMACEUTICALS SA·Filed 2008·Application pending·0 cites
- 1243US10189775B2Carbocyclic compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2016·Granted Jan 29, 2019·0 cites·15 claims
- 1341US2020247800A1Substituted bicyclic heterocyclic compounds as nadph oxidase inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2018·Application pending·0 cites
- 1440US2008182851A1Acetylene derivatives as stearoyl coa desaturase inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2007·Application pending·0 cites
- 1528US9718817B2Aryl and heteroaryl ether compounds as ROR gamma modulatorsGLENMARK PHARMACEUTICALS SA·Filed 2015·Granted Aug 1, 2017·0 cites·28 claims
Join the waitlist — get patent alerts
Get an alert when Daisy M. Shah files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →